Novartis AG
CHIMERIC ANTIGEN RECEPTOR THERAPY IN COMBINATION WITH IL-15R AND IL15
Last updated:
Abstract:
The invention provides compositions and methods for treating diseases such as cancer. The invention also relates to a method of administering a therapy comprising a chimeric antigen receptor, an IL-15R molecule and an IL-15 molecule.
Status:
Application
Type:
Utility
Filling date:
13 Feb 2019
Issue date:
24 Dec 2020